Full Text
Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

Abstract

Authors

RA Assal

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×